Skip to content
ABOUT
Accelerating Bio-Innovation
Royalty Pharma
SPEAKERS
AGENDA
PAST ABIs
2026, Sweden
2026, Cambridge, UK
2025, MIT
2024, Cambridge, UK
2023, MIT
2022, Cambridge, UK
2019, Cambridge, UK
HIGHLIGHTS
AGENDA
TALKS
SPEAKERS
PHOTO GALLERY
ABOUT
Speakers
Karen Akinsanya
Schrödinger
Srini Akkaraju
Samsara BioCapital
Chris Anzalone
Arrowhead Pharmaceuticals
Sangeeta Bhatia
MIT
Emmanuel Caeymaex
UCB
Per-Ola Carlsson
Uppsala University
Thomas Clozel
Owkin
Nicholas Dirks
The New York Academy of Sciences
Tova Gardin
Biohaven
Molly Gibson
Flagship Pioneering
Steve Harr
Sana Biotechnology
Zoë Johnson
Gubra
NOBEL
David Julius
University of California, San Francisco
Adam Keeney
Biogen
Nina Kjellson
Canaan
Sandeep Kulkarni
Zura Bio
Gustav Källstrand
Nobel Prize Museum
BREAKTHROUGH
Robert Langer
MIT
Nanna Lüneborg
Forbion
Jan Møller Mikkelsen
Ascendis Pharma
NOBEL
May Britt Moser
Kavli Institute for Systems Neuroscience
Guido Oelkers
Sobi
Peder Olofsson
Karolinska Institutet
Gunilla Osswald
BioArctic
Roger M. Perlmutter
Eikon Therapeutics
Malte Peters
Tango Therapeutics
NOBEL
Fred Ramsdell
Sonoma Biotherapeutics
Nina Rawal
Emerging Health Ventures
David Redfern
GSK
Julie Rozenblyum
Bristol Myers Squibb
Arthur Sands
Nurix Therapeutics
NOBEL
Randy Schekman
University of California, Berkeley
Arndt Schottelius
Maxion Therapeutics
Richard Siegel
Novartis Biomedical Research
Dan Skovronsky
Eli Lilly and Company
Mårten Steen
HealthCap
Molly Stevens
University of Oxford
Peter Svennilson
The Column Group
Astrid Söderbergh Widding
Nobel Foundation
Marc Tessier-Lavigne
Xaira
Fredrik Tiberg
Camurus
Helen Torley
Halozyme
Outi Vaarala
Orion Pharma
Greg Verdine
LifeMine Therapeutics
Niels Vrang
Gubra
Reid Waldman
Veradermics
Annika Östman Wernerson
Karolinska Institutet
Michelle Xia
Akeso
Zhenping Zhu
Helixon